Steroid sulfatase inhibitors

被引:97
作者
Nussbaumer, P [1 ]
Billich, A [1 ]
机构
[1] Novartis Inst Biomed Res Vienna, A-1235 Vienna, Austria
关键词
arylsulfatase; breast cancer; steroid sulfatase; sulfamate;
D O I
10.1002/med.20008
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Steroid sulfatase (STS) regulates the local production of estrogens and androgens from systemic precursors in several tissues. The enzyme catalyzes the hydrolysis of the sulfate esters of 3-hydroxy steroids, which are inactive transport or precursor forms of the active 3-hydroxy steroids. STS inhibitors are expected to block the local production and, consequently, to reduce the local levels of the hormones. Therefore, they are considered as potential new therapeutic agents for the treatment of estrogen- and androgen-dependent disorders. Indications range from cancers of the breast, endometrium and prostate to androgenetic alopecia and acne. In this review, we give a comprehensive summary of the current knowledge and problems in the field of medicinal chemistry of STS inhibitors. The various types of inhibitors are presented and their structure-activity relationships are discussed. In addition to potent arylsulfamate-based, irreversible inhibitors, novel types of reversible inhibitors were recently discovered. The recent publication of the X-ray structure of STS will further boost research activities oil this attractive target. (C) 2004 Wiley Periodicals, Inc.
引用
收藏
页码:529 / 576
页数:48
相关论文
共 204 条
  • [1] Inhibition of estrone sulfatase (ES) by derivatives of 4-[(aminosulfonyl)oxy] benzoic acid
    Ahmed, S
    James, K
    Owen, CP
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (17) : 2391 - 2394
  • [2] Design, synthesis and biochemical evaluation of AC ring mimics as novel inhibitors of the enzyme estrone sulfatase (ES)
    Ahmed, S
    James, K
    Owen, CP
    Patel, CK
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (10) : 1343 - 1346
  • [3] Review of estrone sulfatase and its inhibitors - An important new target against hormone dependent breast cancer
    Ahmed, S
    Owen, CP
    James, K
    Sampson, L
    Patel, CK
    [J]. CURRENT MEDICINAL CHEMISTRY, 2002, 9 (02) : 263 - 273
  • [4] Hydrophobicity, a physicochemical factor in the inhibition of the enzyme estrone sulfatase (ES)
    Ahmed, S
    James, K
    Owen, CP
    Patel, CK
    Patel, M
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (18) : 2525 - 2528
  • [5] Acid dissociation constant, a potential physicochemical factor in the inhibition of the enzyme estrone sulfatase (ES)
    Ahmed, S
    Owen, CP
    James, K
    Patel, CK
    Patel, M
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (07) : 899 - 902
  • [6] Estrone sulfatase: Probing structural requirements for substrate and inhibitor recognition
    Anderson, C
    Freeman, J
    Lucas, LH
    Farley, M
    Dalhoumi, H
    Widlanski, TS
    [J]. BIOCHEMISTRY, 1997, 36 (09) : 2586 - 2594
  • [7] Pharmacokinetics of oestrone-3-O-sulphamate
    Aragones, MIH
    Purohit, A
    Parish, D
    Sahm, UG
    Pouton, CW
    Potter, BVL
    Reed, MJ
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1996, 58 (5-6) : 611 - 617
  • [8] BALLABIO A, 1995, METABOLIC MOL BASES, P2999
  • [9] Influence of subchronic administration of oestrone-3-O-sulphamate on oestrone sulphatase activity in liver, spleen and white blood cells of ovariectomized rats
    Barth, A
    Römer, W
    Oettel, M
    [J]. ARCHIVES OF TOXICOLOGY, 2000, 74 (07) : 366 - 371
  • [10] New fluorogenic substrate for the first continuous steroid sulfatase assay
    Bilban, M
    Billich, A
    Auer, M
    Nussbaumer, P
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (09) : 967 - 969